Tal Zvi Zaks - 16 Jun 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Medical Officer
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
16 Jun 2021
Net transactions value
-$870,350
Form type
4
Filing time
21 Jun 2021, 19:03:44 UTC
Previous filing
11 Jun 2021
Next filing
25 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise $129,650 +5,000 $25.93 5,000 16 Jun 2021 Direct F1
transaction MRNA Common Stock Sale $1,000,000 -5,000 -100% $200.00 0 16 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -5,000 -3.7% $0.000000 131,120 16 Jun 2021 Common Stock 5,000 $25.93 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021.
F2 25% of this option vested and became exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter.